What is the role of molecular oxygen in the electron transport chain (ETC)?
In chronic alcoholism, which component, excluding enzymes, is rate-limiting for alcohol metabolism?
What is the total number of dehydrogenases in the Krebs cycle?
Which of the following poisons acts by causing inhibition of complex IV of the respiratory chain?
What is true about the transfer of electrons in the electron transport chain?
Malonate inhibits which enzyme of glycolysis?
What is the primary energy currency used by cells?
Which factor is least important in the final pathway of electron transport chain reactions?
Among the following, which has the maximum redox potential?
Which enzyme is a marker of the electron transport system?
Explanation: **Explanation:** **1. Why the Correct Answer is Right:** In the Electron Transport Chain (ETC), molecular oxygen ($O_2$) serves as the **terminal (final) electron acceptor**. This process occurs at **Complex IV (Cytochrome c Oxidase)**. Here, oxygen accepts four electrons and four protons ($H^+$) to be reduced into two molecules of water ($H_2O$). This step is crucial because it allows the flow of electrons to continue; without oxygen, the ETC stalls, the proton gradient collapses, and ATP production ceases. **2. Analysis of Incorrect Options:** * **Option A:** Transfer of reducing equivalents to Coenzyme Q is performed by **Complex I** (from NADH) and **Complex II** (from FADH₂). Oxygen does not interact with Coenzyme Q directly. * **Option B:** This refers to **Shuttle Pathways** (such as the Malate-Aspartate or Glycerol-3-Phosphate shuttles), which transport cytosolic NADH into the mitochondrial matrix. * **Option D:** While oxygen is necessary for the ETC to function, the actual generation of ATP is performed by **Complex V (ATP Synthase)** through the movement of protons back into the matrix, a process driven by the electrochemical gradient (Chemiosmotic Theory). **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Cyanide and Carbon Monoxide (CO) Poisoning:** Both inhibit **Complex IV** by binding to the iron in heme, preventing oxygen from accepting electrons. This leads to "histotoxic hypoxia." * **P/O Ratio:** For every NADH oxidized, ~2.5 ATP are formed; for every $FADH_2$, ~1.5 ATP are formed. * **Reactive Oxygen Species (ROS):** Partial reduction of $O_2$ (instead of full reduction to $H_2O$) leads to the formation of free radicals like superoxide ($O_2^{\cdot-}$), primarily at Complexes I and III.
Explanation: **Explanation:** Alcohol metabolism primarily occurs in the liver via two sequential oxidative steps. First, **Alcohol Dehydrogenase (ADH)** converts ethanol to acetaldehyde. Second, **Acetaldehyde Dehydrogenase (ALDH)** converts acetaldehyde to acetate. Both of these reactions require **NAD+ (Nicotinamide Adenine Dinucleotide)** as a mandatory co-substrate, which is reduced to **NADH**. In chronic alcoholism, the high rate of ethanol oxidation rapidly depletes the cellular pool of NAD+ and significantly increases the **NADH/NAD+ ratio**. Because the liver cannot regenerate NAD+ fast enough to keep up with high alcohol intake, **NAD+ becomes the rate-limiting factor** for further metabolism. **Analysis of Options:** * **Option A (NADP):** While NADPH is used by the Microsomal Ethanol Oxidizing System (MEOS), it is not the primary rate-limiting co-substrate for the major oxidative pathway. * **Option D (FADH):** FAD/FADH₂ are involved in the Electron Transport Chain and other metabolic cycles (like the TCA cycle) but are not direct co-factors for ADH or ALDH. * **Option C (None):** Incorrect, as the availability of NAD+ dictates the velocity of ethanol clearance. **Clinical Pearls for NEET-PG:** 1. **High NADH/NAD+ Ratio Effects:** This shift inhibits gluconeogenesis (leading to **fasting hypoglycemia**), inhibits the TCA cycle, and promotes the conversion of pyruvate to lactate (causing **lactic acidosis**). 2. **Fatty Liver:** The excess NADH signals the body to increase fatty acid synthesis and decrease β-oxidation, leading to **steatosis**. 3. **Disulfiram:** This drug inhibits ALDH, causing an accumulation of acetaldehyde, which leads to the "hangover" symptoms used in aversion therapy.
Explanation: ### Explanation The Krebs cycle (Tricarboxylic Acid Cycle) is the final common pathway for the oxidation of carbohydrates, lipids, and proteins. The correct answer is **4** because there are exactly four oxidation-reduction steps catalyzed by specific dehydrogenase enzymes within the cycle. **Why 4 is correct:** The four dehydrogenases involved in the cycle are: 1. **Isocitrate Dehydrogenase:** Converts Isocitrate to $\alpha$-Ketoglutarate (Produces NADH). 2. **$\alpha$-Ketoglutarate Dehydrogenase:** Converts $\alpha$-Ketoglutarate to Succinyl-CoA (Produces NADH). 3. **Succinate Dehydrogenase:** Converts Succinate to Fumarate (Produces $\text{FADH}_2$). 4. **Malate Dehydrogenase:** Converts Malate to Oxaloacetate (Produces NADH). **Why other options are incorrect:** * **A (3) & B (2):** These underestimate the oxidative steps. Students often forget Succinate Dehydrogenase because it produces $\text{FADH}_2$ instead of NADH, or they overlook Malate Dehydrogenase. * **D (5):** This is a common confusion. **Pyruvate Dehydrogenase (PDH)** is often mistaken as part of the cycle; however, PDH is a "link reaction" enzyme that converts Pyruvate to Acetyl-CoA *before* the cycle begins. **High-Yield Facts for NEET-PG:** * **Location:** All enzymes are in the mitochondrial matrix except **Succinate Dehydrogenase**, which is located on the **inner mitochondrial membrane** (also known as Complex II of the ETC). * **Rate-Limiting Step:** Isocitrate Dehydrogenase is the primary rate-limiting enzyme. * **Cofactors:** $\alpha$-Ketoglutarate Dehydrogenase requires five cofactors: Thiamine (B1), Riboflavin (B2), Niacin (B3), Pantothenic acid (B5), and Lipoic acid. * **ATP Yield:** One turn of the cycle produces **10 ATP** (3 NADH = 7.5, 1 $\text{FADH}_2$ = 1.5, 1 GTP = 1).
Explanation: **Explanation:** The question asks for the inhibitor of **Complex IV** (Cytochrome c oxidase). However, there is a discrepancy in the provided key: **Malonate is actually an inhibitor of Complex II**, while Cyanide, H₂S, and CO are all inhibitors of Complex IV. **1. Understanding the Correct Mechanism (Complex IV Inhibitors):** Complex IV (Cytochrome c oxidase) is the final enzyme of the electron transport chain. It transfers electrons to oxygen to form water. Inhibitors of this complex bind to the heme iron (Fe³⁺ or Fe²⁺), halting ATP production and causing cellular asphyxiation. * **Cyanide (CN⁻):** Binds to the ferric iron (Fe³⁺) in Cytochrome a3. * **Carbon Monoxide (CO):** Binds to the ferrous iron (Fe²⁺) in Cytochrome a3. * **Hydrogen Sulfide (H₂S):** Potent inhibitor similar to cyanide. * **Azide (N₃⁻):** Also inhibits Complex IV. **2. Analysis of Options:** * **Malonate (Option B):** This is a **competitive inhibitor of Succinate Dehydrogenase (Complex II)**. It is a structural analog of succinate. In the context of the question provided, if Malonate is marked "correct," it is likely a typographical error in the source, as it does not inhibit Complex IV. * **Cyanide, H₂S, and CO (Options A, C, D):** All three are classic inhibitors of **Complex IV**. **3. High-Yield NEET-PG Clinical Pearls:** * **Complex I Inhibitors:** Rotenone, Amobarbital (Amytal), Piericidin A. * **Complex III Inhibitors:** Antimycin A, British Anti-Lewisite (BAL). * **Complex V (ATP Synthase) Inhibitor:** Oligomycin. * **Uncouplers:** 2,4-Dinitrophenol (DNP), Thermogenin (Brown fat), high-dose Aspirin. These increase oxygen consumption but decrease ATP synthesis, generating heat. * **Cyanide Poisoning Antidote:** Amyl nitrite (creates methemoglobin to sequester cyanide) and Sodium thiosulfate (converts cyanide to thiocyanate).
Explanation: ### Explanation **1. Why Option A is Correct:** The Electron Transport Chain (ETC) functions on the principle of a **Redox Potential Gradient**. Electrons flow spontaneously from a carrier with a more negative redox potential (stronger reducing agent) to one with a more positive redox potential (stronger oxidizing agent). Therefore, the complexes are arranged in **increasing order of redox potential**, with NADH having the lowest potential (-0.32 V) and Oxygen having the highest (+0.82 V), acting as the final electron acceptor. **2. Why the Other Options are Incorrect:** * **Option B:** While this path exists for NADH, it is **incomplete**. Electrons from FADH2 enter via Complex II. The complete flow is: Complex I/II → Coenzyme Q → Complex III → Cytochrome c → Complex IV. * **Option C:** This is thermodynamically incorrect. Electrons move from a **higher energy state to a lower energy state**. The energy released during this "downhill" transfer is what powers the pumping of protons across the inner mitochondrial membrane. * **Option D:** When **NADH** enters (Complex I), 10 protons are pumped. However, when **FADH2** enters (Complex II), it bypasses the first proton pump; therefore, only **6 protons** are translocated (4 from Complex III and 2 from Complex IV). **3. NEET-PG High-Yield Pearls:** * **Complex II (Succinate Dehydrogenase):** The only complex that does **not** pump protons and is also a member of the TCA cycle. * **Mobile Carriers:** Coenzyme Q (Ubiquinone) is lipid-soluble; Cytochrome c is water-soluble and located in the intermembrane space. * **Inhibitors (Must-know):** * Complex I: Rotenone, Amytal. * Complex III: Antimycin A. * Complex IV: Cyanide, CO, Azide, H2S. * Complex V (ATP Synthase): Oligomycin.
Explanation: **Explanation:** The question contains a common conceptual trap: **Malonate does not inhibit an enzyme of glycolysis; it inhibits an enzyme of the Citric Acid Cycle (TCA Cycle).** Among the options provided, Succinate Dehydrogenase is the correct target. **1. Why Succinate Dehydrogenase is Correct:** Malonate is a classic example of a **competitive inhibitor**. It is a structural analogue of **succinate** (the substrate for succinate dehydrogenase). Because of its structural similarity, malonate competes for the active site of the enzyme **Succinate Dehydrogenase (Complex II)**, thereby blocking the conversion of succinate to fumarate. This inhibition halts the TCA cycle and the Electron Transport Chain. **2. Why Other Options are Incorrect:** * **Aconitase:** Inhibited by **Fluoroacetate** (which is converted to fluorocitrate, a "suicide inhibitor"). * **Alpha-ketoglutarate dehydrogenase:** Inhibited by **Arsenite** and high levels of Ammonia. It requires five cofactors (Thiamine, Lipoic acid, CoA, FAD, NAD). * **Isocitrate dehydrogenase:** This is the rate-limiting enzyme of the TCA cycle, primarily regulated by the **ATP/ADP ratio** and NADH levels, not by malonate. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Location:** Succinate Dehydrogenase is the **only** enzyme of the TCA cycle located in the **inner mitochondrial membrane** (others are in the matrix). It also functions as **Complex II** of the Electron Transport Chain. * **Competitive Inhibition:** In competitive inhibition, **$V_{max}$ remains unchanged**, but **$K_m$ increases**. This can be overcome by increasing the concentration of the substrate (succinate). * **Glycolysis vs. TCA:** Always read the question carefully. While the question asks about "glycolysis," the options provided are all TCA cycle enzymes. In such cases, select the biochemically accurate inhibitor-enzyme pair.
Explanation: **Explanation:** **Correct Option: A. Glucose** In the context of systemic metabolism, **Glucose** is considered the primary energy currency or the "universal fuel" for the human body. It is the most significant source of energy because it is the only fuel that can be utilized by all tissues. Specifically, the brain and red blood cells (RBCs) are obligate glucose users; RBCs lack mitochondria and depend entirely on anaerobic glycolysis of glucose for survival. **Analysis of Incorrect Options:** * **B. ATP (Adenosine Triphosphate):** While often called the "energy currency of the cell," ATP is technically the **immediate chemical energy carrier**. In many competitive exams, if the question asks for the primary *metabolic fuel* or the currency supplied via the bloodstream to tissues, Glucose is the preferred answer. * **C. Fructose:** This is a monosaccharide primarily metabolized in the liver. It is not the primary systemic energy source and must be converted into glycolytic intermediates to produce energy. * **D. NADP:** Nicotinamide Adenine Dinucleotide Phosphate is a **coenzyme** involved in reductive biosynthesis (like fatty acid synthesis) and antioxidant defense (PPP pathway), not a primary energy fuel. **NEET-PG High-Yield Pearls:** * **Obligate Glucose Users:** Brain (uses ~120g/day), RBCs, Renal Medulla, and Retina. * **Normal Fasting Blood Glucose:** 70–100 mg/dL. * **GLUT-4:** The only insulin-dependent glucose transporter, found in skeletal muscle and adipose tissue. * **RBC Metabolism:** Since RBCs lack mitochondria, they produce 2,3-BPG via the Rapoport-Luebering shunt to regulate oxygen affinity.
Explanation: In the Electron Transport Chain (ETC), the rate of ATP synthesis is primarily governed by **respiratory control**, where the availability of substrates and the electrochemical gradient are the limiting factors, rather than the absolute concentration of enzymes. ### Why Enzyme Concentration is the Correct Answer In metabolic pathways, enzymes are typically present in excess relative to their substrates. In the ETC, the protein complexes (I-IV) and ATP synthase are fixed structural components of the inner mitochondrial membrane. Their concentration does not fluctuate rapidly to regulate the reaction rate. Instead, the "flux" through these enzymes is determined by the availability of ADP, Pi, and reduced coenzymes (NADH/FADH₂). Therefore, **enzyme concentration** is the least important factor in the immediate regulation of the final pathway. ### Analysis of Other Options * **pH (Option A):** The ETC functions by creating a **proton gradient**. The pH difference ($\Delta$pH) between the intermembrane space and the matrix is the driving force (Proton Motive Force) for ATP synthesis. Any significant change in pH disrupts this gradient. * **Temperature (Option B):** Like all biochemical reactions, ETC enzymes are temperature-dependent. High temperatures can denature the complexes, while low temperatures decrease kinetic energy, slowing down electron flow. * **Substrate Concentration (Option D):** This is the most critical regulator. According to the principle of **respiratory control**, the rate of the ETC is directly proportional to the concentration of **ADP** (the primary substrate for ATP synthase). ### NEET-PG High-Yield Pearls * **Respiratory Control:** The regulation of the rate of oxidative phosphorylation by the level of ADP is known as respiratory control. * **Uncouplers (e.g., 2,4-DNP):** These increase the permeability of the inner membrane to protons, collapsing the pH gradient. This increases oxygen consumption (ETC speed) but stops ATP synthesis, dissipating energy as heat. * **Complex IV Inhibitors:** Cyanide and Carbon Monoxide bind to the ferric ($Fe^{3+}$) and ferrous ($Fe^{2+}$) states of iron in Cytochrome $aa_3$, respectively, completely halting the final pathway.
Explanation: ### Explanation In the Electron Transport Chain (ETC), electrons flow from carriers with a **lower (more negative) redox potential** to those with a **higher (more positive) redox potential**. Redox potential ($E_0'$) measures the affinity of a substance for electrons; the more positive the value, the greater the tendency to accept electrons (act as an oxidant). **Why Fe²⁺ is Correct:** In the final stages of the ETC (Complex IV or Cytochrome Oxidase), electrons are transferred through various iron-sulfur centers and cytochromes. Among the options provided, the iron ions ($Fe^{2+}/Fe^{3+}$) within the cytochromes—specifically **Cytochrome a3**—possess the highest redox potential before finally passing electrons to oxygen (the ultimate electron acceptor with the highest potential of all, +0.82 V). **Analysis of Incorrect Options:** * **A. NADH/NAD:** This has the **lowest (most negative)** redox potential (~ -0.32 V). It sits at the top of the chain and acts as the primary electron donor. * **B. Succinyl CoA/Fumarate:** (Note: Usually referred to as Succinate/Fumarate in ETC). This enters at Complex II. Its potential is higher than NADH but significantly lower than the cytochromes (~ +0.03 V). * **C. Ubiquinone (Coenzyme Q):** This acts as a mobile collector of electrons from Complexes I and II. Its redox potential is intermediate (~ +0.10 V), higher than NADH but lower than the cytochromes. **High-Yield Clinical Pearls for NEET-PG:** * **Direction of Flow:** Electrons always move from **Negative $E_0'$** (Strong Reducer) $\rightarrow$ **Positive $E_0'$** (Strong Oxidizer). * **The "Final" Step:** Oxygen has the maximum redox potential in the entire respiratory chain. * **Inhibitor Correlation:** Cyanide and Carbon Monoxide inhibit **Complex IV** (Cytochrome a3), blocking the site with the highest redox potential among the protein complexes, leading to cellular hypoxia. * **Energy Release:** The greater the difference in redox potential ($\Delta E_0'$) between two carriers, the more free energy ($\Delta G$) is released to pump protons.
Explanation: **Explanation:** The Electron Transport Chain (ETC) is located on the **inner mitochondrial membrane**. To identify or "mark" this specific system in biochemical assays, scientists look for enzymes that are exclusively localized there. **1. Why Cytochrome Reductase is correct:** Cytochrome reductase (also known as **Complex III** or Coenzyme Q-Cytochrome c reductase) is an integral component of the respiratory chain. It facilitates the transfer of electrons from ubiquinol to cytochrome c. Because it is structurally and functionally embedded within the inner mitochondrial membrane as part of the oxidative phosphorylation machinery, it serves as a definitive **marker enzyme for the Electron Transport System.** **2. Why the other options are incorrect:** * **Fumarase & Malate Dehydrogenase:** These are enzymes of the **Citric Acid Cycle (TCA cycle)**. They are primarily located in the **mitochondrial matrix** (though a cytosolic isoenzyme of malate dehydrogenase exists). They are markers for the matrix, not the ETC. * **Pyruvate:** This is a substrate (a keto-acid), not an enzyme. Pyruvate dehydrogenase (the enzyme complex) is also located in the mitochondrial matrix. **High-Yield Clinical Pearls for NEET-PG:** * **Marker for Outer Mitochondrial Membrane:** Monoamine Oxidase (MAO). * **Marker for Intermembrane Space:** Adenylate kinase. * **Marker for Mitochondrial Matrix:** Citrate synthase (often tested alongside Malate dehydrogenase). * **Complex II (Succinate Dehydrogenase):** This is the only TCA cycle enzyme that is also a component of the ETC (inner membrane), making it a unique dual-functional marker.
Bioenergetics and Thermodynamics
Practice Questions
ATP as Energy Currency
Practice Questions
Tricarboxylic Acid Cycle
Practice Questions
Electron Transport Chain
Practice Questions
Oxidative Phosphorylation
Practice Questions
Mitochondrial Diseases
Practice Questions
Uncouplers and Inhibitors of Oxidative Phosphorylation
Practice Questions
Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate
Practice Questions
Energy Yield from Nutrients
Practice Questions
Metabolic Rate and Basal Metabolism
Practice Questions
Brown Adipose Tissue and Thermogenesis
Practice Questions
Oxygen Toxicity and Free Radicals
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free